with ESRD and chronic renal failure (CRF) is a matter of great relevance. There has been much debate regarding the level of residual renal function at which dialysis should be begun, and in this editorial review we will examine issues surrounding the timing of initiation of dialysis.
Traditionally, the decision regarding when dialysis should be started has been based on a combination of uremic symptoms and laboratory findings. The presence of life-threatening complications of renal failure -such as encephalopathy, pericarditis, pulmonary edema, poorly controlled hypertension, severe hyperkalemia or metabolic acidosis and bleeding diathesis -are accepted as absolute indications for commencing dialysis. The presence of symptoms that greatly affect quality of lifesuch as gastrointestinal or neurologic symptoms and pruritus -are relative indications (6). Uremic symptoms are very subjective and may be influenced by comorbid conditions, medication side effects, poor communication, and denial of disease. Furthermore, symptoms do not correlate reliably with laboratory indices of renal function. In a study of 402 incident dialysis patients, Malangone et al found no association between serum creatinine, blood urea nitrogen (BUN), or creatinine clearance and the severity of signs and symptoms of uremia (7). The optimal level of residual renal function for starting dialysis, and the best method for assessing residual renal function are not universally agreed upon.
The precise estimation of renal function is important in deciding when to start renal replacement therapy. Although glomerular filtration rate (GFR) is considered the most accurate measure of renal function (8), it is difficult to measure in clinical practice. Creatinine clearance (CrCl) measurements with timed urine collections provide a reasonable estimate of GFR, but the required precise collection is difficult to obtain. Clinicians most commonly use serum creatinine (SCr) concentration as an indicator of the level of renal function. This, however, is affected by factors other than GFR, such as age, gender, race, muscle mass, nutrition, and dietary meat intake. With progressive renal insufficiency there is often reduced creatinine generation related to loss of muscle mass, malnutrition and restriction of meat intake (9), and increased tubular secretion and extra-renal excretion of creatinine (10) . Consequently, SCr levels and CrCl can underestimate the severity of renal insufficiency, as a low or stable SCr concentration could reflect loss of muscle mass rather than improvement or stabilization of renal function (11) . Therefore a number of equations have been developed which provide a more accurate estimation of renal function from SCr. The most familiar is the Cockroft-Gault equation, which estimates CrCl and as such may overestimate the level of renal function. Equations that estimate GFR include the Walser equation (12) and the equations derived from the African-American Study of Kidney Disease and Hypertension (AASK) (13) and the Modification of Diet in Renal Disease (MDRD) Study (14) . Estimates of GFR, rather than creatinine clearance, more accurately represent renal function, and should probably be used in combination with uremic manifestations to decide when to start dialysis.
The level of renal function at which chronic dialysis should be initiated has long been debated. Proponents of early dialysis have suggested that this attenuates complications of uremia such as malnutrition and cardiovascular disease, and consequently would reduce morbidity, mortality and cost (15) (16) (17) (18) . Early dialysis was championed over two decades ago by Bonomini and colleagues in Bologna, Italy, following a study of 103 patients with various levels of renal function who received dialysis of differing intensity (15) . Patients were divided into five groups: group I, CrCl < 5 ml/min, 'standard' 2-3 times weekly dialysis; group II, CrCl < 5 ml/min, daily dialysis; group III, CrCl 5-15 ml/min, dialysis 3 times weekly; group IV, 15-25 ml/min, dialysis 3 times weekly; group V, CrCl 15-25 ml/min, on severe protein restriction. They studied subclinical markers of uremia such as nerve conduction velocity, biochemical markers and renal osteodystrophy. They noted no improvement in group I, group II had improvement, group III and IV had minimal impairment in the subclinical markers at 3-4 years of follow-up, and group V had progressive worsening. From the good outcomes of group IV the investigators concluded that early dialysis was beneficial and began espousing early initiation. However, group I fared extremely poorly (14% 6-year survival) when compared to contemporaneous results reported elsewhere, but underdialysis and a high number of comorbid illnesses may have contributed (19) . Comparing group II, or patients receiving 'adequate dialysis', with groups III and IV, no difference in the uremic parameters was found. The critics of this study therefore concluded that early dialysis had no beneficial effects on objective parameters and inflicted unnecessary dialysis for up to 5 years (19) . Despite the authors' recommendation, early dialysis did not become accepted practice.
Opponents of early dialysis believe that a healthy nutritional status can be maintained with careful management until dialysis becomes inevitable (19) (20) (21) (22) (23) . Dietary protein restriction has been the cornerstone of conservative therapy for patients with CRF, with the presumed benefit of delaying the appearance of uremic symptoms and slowing the rate of progression of renal failure (22, 24) . However, studies regarding the benefits of dietary protein restriction are inconclusive (25) , and a potential risk for malnutrition remains. Early dialysis could also reduce survival of the vascular access or peritoneal membrane and expose the patient to other adverse consequences associated with dialysis, such as sepsis, hypotension, and repeated invasive interventions. There would be a needless early imposition of lifestyle restrictions and increased costs. There is an additional concern of possibly hastening the decline in residual renal function (26) , arising from the observation that hemodialysis patients have a more rapid decline in renal function than those on peritoneal dialysis (27) (28) (29) . Such studies, however, have yielded contradictory results. Bonomini and colleagues retrospectively compared residual renal function between patients who began dialysis (23) and patients who received conservative treatment with a low protein diet (26) . The patients were matched for age, gender, cause of CRF and creatinine clearance. After one year, creatinine clearance declined from 10.9 ± 2.5 to 8.6 ± 2.1 ml/min in the dialysis group, and from 11.2 ± 3.2 to 2.5 ± 1.8 ml/min in the conservatively managed group. Creatinine clearance levels low enough to make dialysis obligatory were reached in four years in the early dialysis group. By contrast Barsotti et al (30) reported a decline in residual renal function of 1.38 ± 0.77 ml/min/month after the beginning of dialysis compared with a decline of 0.60 ± 0.30 ml/min/month in patients not yet on dialysis. Seemingly opposite results could potentially occur due to differences in baseline renal function, intradialytic complications, such as hypotensive episodes, and medication use. Whether early initiation results in more rapid decline in residual renal function remains unresolved.
Despite these controversies, there are feasible explanations for more favorable clinical outcomes with earlier dialysis. These are based on the prevention of malnutrition, improved solute clearance, and limited clinical studies. Numerous studies have suggested that malnutrition at the initiation of dialysis is associated with increased morbidity and mortality (9, 31-33). It has been shown that patients with lower serum albumin levels at initiation of dialysis have higher mortality than patients with higher serum albumin levels (32) (33) (34) . Moreover, baseline serum albumin levels appear to have independent predictive value for mortality even after several years of dialysis (35) . Malnutrition among patients with progressive renal insufficiency may occur for several reasons. There is spontaneous dietary protein and calorie restriction, abnormal protein metabolism related to metabolic acidosis, insulin resistance and probably other unidentified factors associated with uremia, and increased requirements for essential amino acids and nitrogen (9, 33, 36).
There is evidence showing a strong association between dose of dialysis and morbidity and mortality (35, 37) . However, patients are generally started on dialysis when their endogenous solute clearance is lower than what is recommended as maintenance for patients on dialysis. Tattersall reported that the mean weekly renal Kt/V of 63 patients who began dialysis in the United Kingdom was 0.85 (31) and in the CANUSA study, the mean weekly renal Kt/V of 680 patients who began peritoneal dialysis in 14 centers in the USA and Canada was only 0.71 (33) . In the United States the mean GFR at initiation of dialysis, estimated using the equation derived from the MDRD Study (14) , was 7.1 ml/min/1.73 m 2 (38) . These are much lower than the recommended maintenance clearance targets of Kt/V urea of 3.6 and 2.0 for hemodialysis (39) and CAPD (35) , respectively. These results suggest that there are dual standards with respect to defining the optimum level of clearance of uremic toxins: one for patients already on dialysis, and one for determining when patients should begin dialysis. In addition to suboptimal clearance of nitrogenous waste products, decreased clearance of phosphate, advanced glycosylation end-products, β 2 -microglobulin and other undefined uremic toxins, and inadequate control of volume overload may contribute to increased morbidity and mortality related to delaying dialysis.
Although no prospective randomized clinical trials are available, a few observational studies suggest that early initiation of dialysis may yield improved outcomes. Bonomini and colleagues in Italy have advocated starting dialysis when the creatinine clearance is still above 10 ml/min and even as high as 15 -20 ml/min (15) . He reported that survival, hospital utilization, mean nerve conduction velocity, bone biopsies, lipid and amino acid metabolism, and employment were better in the patients dialyzed earlier (16, 40) . These studies, however, were not randomized, the doses of dialysis were not similar, and 'lead-time' bias was not considered. That is, the observed benefit may simply reflect the duration of time the patients would have been free of the complications of uremia anyway, and not an alteration of the course of the disease. More recently Tattersall (31) reported similar conclusions from a retrospective study of 63 patients. He found a higher number of hospital days among patients with an initial daily renal Kt/V urea < 0.15 (25.1 days) compared with patients with Kt/V urea ≥ 0.15 (10.6 days) at initiation of dialysis. In addition, patients who died had a daily Kt/V urea of 0.09, significantly lower than the Kt/V urea of 0.15 among the survivors. The results of the CANUSA study further suggest a survival advantage of a higher level of renal function at the beginning of dialysis. Patients with a mean initial clearance of 63 L/week had a 2-year survival of 82% compared to a 2-year survival of 74% for patients with a mean clearance of 19 L/week (p=0.015; log-rank). The multivariate analysis showed the relative risk for death to be 0.95 (95% CI 0.91-0.99) for each five L/week higher initial clearance (33) . In summary, despite the limitations of the few available studies and the difficulty in directly comparing different measures of clearance, the results support the notion that earlier dialysis is associated with a superior outcome.
There has been a steady trend toward starting dialysis at lower serum creatinine levels in the United States, perhaps because of the previously discussed results. Between 1963 and 1977 the mean serum creatinine at the start of dialysis among patients at the Mayo Clinic was 14.5 mg/dl (41) . Between 1969 and 1983 the mean serum creatinine and the CrCl (calculated by the Cockcroft-Gault formula) at the start of dialysis among patients in Rhode Island were 11.7 mg/dl and 7 ml/min respectively (7). Among two nationally representative samples of patients who began dialysis during the years 1986-1987 and 1990-1991, the mean serum creatinine levels adjusted for age, sex, race, and cause of ESRD were 9.9 mg/dl and 9.0 mg/dl (42) . More recently the mean serum creatinine in patients starting dialysis in the United States between 1995 and 1997 was 8.5 mg/dl and the calculated GFR was 7.1 ml/min/1.73 m 2 (38) .
Despite the lack of firm evidence, the 1997 National Kidney Foundation -Dialysis Outcomes Quality Initiative (NKF DOQI TM ) guidelines recommend that patients should begin dialysis when the GFR falls below 10.5 ml/min/1.73 m 2 (approximates a Kt/V urea of 2.0), unless edema-free body weight is stable or increased, the normalized protein nitrogen appearance (nPNA) rate is ≥ 0.8 g/kg/day, and there are no clinical signs or symptoms of uremia (43) . More recently, the Canadian Society of Nephrology has recommended that dialysis should begin when GFR is less than 12 ml/min if evidence of uremia or malnutrition (nPNA < 0.8 g/kg/day or clinical evidence of malnutrition) exists. The GFR value of 12 ml/min corresponds approximately to a CrCl of 18 ml/min and a weekly Kt/V of 2.0 (44).
The importance of early nephrology referral must be briefly discussed, as timely dialysis initiation is impossible without it. It has been estimated that only 20 to 25% of patients with CRF are referred to a nephrologist prior to the imminent need to start dialysis (45) . Several investigators (46) (47) (48) (49) (50) have shown that delayed nephrology referral causes increased hospital utilization, costs, morbidity and mortality. At the University of Missouri, Campbell and colleagues reported that the one-year mortality rates for urgent (<1 month prior to dialysis start), intermediate (1-4 months), and delayed (>4 months) referral were 39%, 19%, and 6% (48). Ratcliffe et al (47) at the University of Oxford reported that delayed (> 1 month) referral was associated with major complications in 16 (70%) patients and death in 3 (13%) patients. In contrast, in the early referral group only 3 (9%) patients suffered complications and 1 (4%) patient died. Other adverse effects associated with delayed referral included inappropriate choice of dialysis modality, lack of a permanent vascular access, and more severe metabolic abnormalities. A recent study from our center revealed that compared with early referral, patients referred within 4 months of required dialysis start (late referral) were more likely to have hypoalbuminemia (80% vs 56%), hematocrit < 28% (55% vs 33%), GFR < 5 ml/min/1.73 m 2 (40% vs 17%), and less likely to have received erythropoietin (17% vs 40%) and to have a functioning permanent vascular access for the first hemodialysis (4% vs 40%) (51) . The lack of timely referral is a problem possibly more important than late initiation of dialysis.
A discussion of the controversies surrounding the timing of initiation of dialysis must consider the potential clinical and societal implications of early initiation of dialysis. The possible advantages of early initiation of dialysis -prevention of uremic symptoms and progression of CRF, decreased hospital utilization and improved rehabilitation -must be weighed against the life-style restrictions and the economic burden of early initiation when the impairment in renal function is not yet associated with significant apparent morbidity. It is possible, but as yet unknown, that reductions in hospital utilization and improved work rehabilitation may counteract this cost. As with any clinical decision, the patients' understanding, wishes, and acceptance must remain a major deciding factor. The full resolution of the debate regarding early versus late initiation of dialysis requires identification of the sequelae of uremia that adversely affect patient outcomes and objective confirmation that they are preventable by early initiation of dialysis. In the absence of firm data, the current recommendations of several national and international organizations are the sole guidelines, which should be accompanied by careful clinical assessment of the individual patient. 
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